covid-19 vaccine candidates developed by the University of Oxford and US-based company Novavax.The apex biomedical research agency is also helping Zydus Cadila conduct lab tests to detect antibody response, shows documents reviewed by Mint.
On Wednesday, the ICMR made a presentation, detailing all covid-related measures it has been taking, before members of the parliamentary sta-nding committee on home affairs.According to people in the know, ICMR director general Dr Balram Bhargava told the panel that the Oxford University vaccine candidate will start phase 2 trials in India by the end of this week, and around 1,600 subjects have been identified across 17 centres.In clinical trials, every site is monitored by a committee ensuring ethical.